摘要
Recently,artemisinin and derivatives have been revealedto possessencouraging antitumor activity. Herein, we integrated the antitumoradvantages of artesunate and platinum drugs to construct novel Pt-IV-artesunate dual-action and triple-action complexes.Most derivatives, especially 10f, displayed broad-spectrumand potent in vitro antitumor activities againsta number of cancer cell lines. Compound 10f displayedpotent antimetastasis and anticlonogenic activities, efficiently inducedautophagic cell death and apoptosis, and arrested the cell cycle atboth S and G2/M phases. More importantly, it displayed remarkable in vivo antitumor efficacy in the A549 xenograft model (TGI= 53.4%; 6 mu mol/kg) with low toxicity. In addition to the antitumorapplication, 10f showed potent in vivo antimalarial activity in malarial-infected mice model and obviouslyalleviated malarial-related multiorgan injury. This conjugation greatlyimproved safety, especially reducing the platinum drugs' nephrotoxicity.Taken together, this study highlighted the therapeutic potential ofPt(IV)-artesunate complexes as antitumor and antimalarialagents.
学科与关键词
- Synthesis, Characterization, and Cytotoxicity of a Reactive Platinum(IV) Monotrifluoromethyl ComplexLiu, Yanpeng; Yao, Houzong; Tse, Man-Kit; Chen, Shu; Yiu, Shek-Man; Zhu, Guangyu*European Journal of Inorganic Chemistry, 2023, 26(3).
- Beyond mere DNA damage: Recent progress in platinum(IV) anticancer complexes containing multi-functional axial ligandsDeng, Zhiqin; Zhu, Guangyu*Current Opinion in Chemical Biology, 2023, 74: 102303.被引 10
- Ruthenium-dihydroartemisinin complex: a promising new compound for colon cancer prevention via G1 cell cycle arrest, apoptotic induction, and adaptive immune regulationWang, Chong-Zhi*; Wan, Chunping; Li, Cang-Hai; Liang, Guo-Gang; Luo, Yun; Zhang, Chun-Feng; Zhang, Qi-Hui; Ma, Qinge; Wang, Angela H.; Lager, Mallory; Jiang, Ting-Liang; Hou, Lifei; Yuan, Chun-SuCancer Chemotherapy and Pharmacology, 2024.
